Back to results

CompletedPhase 2

A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

NCT00702143

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Phoenix, Arizona, United States

+14 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-06
Enrollment: 184 participants
Sponsor: Avid Radiopharmaceuticals
Purpose: diagnostic

Locations (15)

Research SitePhoenix, Arizona, United States
Research SiteScottsdale, Arizona, United States
Research SiteSun City, Arizona, United States
Research SiteTucson, Arizona, United States
Research SiteCosta Mesa, California, United States
Research SiteNew Haven, Connecticut, United States
Research SiteHallandale, Florida, United States
Research SiteMiami Beach, Florida, United States
Research SiteSt. Petersburg, Florida, United States
Research SiteSunrise, Florida, United States
Research SiteWest Palm Beach, Florida, United States
Research SiteAlbany, New York, United States
Research SiteWinston-Salem, North Carolina, United States
Research SiteJenkintown, Pennsylvania, United States
Research SiteBennington, Vermont, United States

A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) — TrialFind